What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
No co-sponsors yet.
History
- Referred to health
- Referred to health
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to prohibiting human reproductive cloning, facilitating stem cell research, and protecting human subjects
Purpose
Authorizes the conduct of stem cell research, requires informed consent, prohibits human reproductive cloning
Summary of provisions
Adds new article 24-A-1 on Stem Cell Research; Human Cloning prohibited.
Sections *2450 Short title *2451 Definitions *2452 Legislative intent *2453 State policy *2454 Fertility and embryo information *2455 Informed consent *2456 Prohibition *2457 commission on cloning and therapeutic research *2458 prohibits reproductive cloning *2459 State funding *2460 Separability
Existing law
None.
Justification
An estimated one hundred twenty-eight million Americans suffer from the crippling economic, physical, and psychological burdens of chronic, degenerative, and acute diseases, including diabetes, Parkinson's disease, cancer, and Alzheimer's disease. The costs of treatment and lost productivity of chronic, degenerative, and acute diseases in the united States constitute hundreds of billions of dollars every year. Estimates of the economic costs of these diseases do not account for the extreme human loss and suffering associated with these conditions.
Stem cell research, including both adult and embryonic research, offers immense promise for developing new medical therapies for these debiltating diseases and a critical of biology. Stem cell means to explore fundamental questions research could lead to unprecedented treatments and potential cures for diabetes, Alzheimer's disease, cancer, and other diseases.
New York supports stem cell research as an avenue for the development of affordable and accessible treatments for these varied public health threats. New York has historically been a haven for open scientific inquiry and technological innovation, and this environment, coupled with the commitment of public and private resources, has made New York the preeminent world leader in biomedicine and biotechnology. New York will take a leadership role in supporting stem cell research, both for the cures that are promised and for the advancements that will result from developing this platform technology.
The biomedical industry is a potentially significant component of New York State's economy. New York's biomedical industry is a critical component of the state's economy which provides substantial employment, pays substantial wages and salaries, invests billions of dollars in research, reports billions of dollars in worldwide revenue,
and will be considerably enhanced by New York state's support of stem cell research.
Stem cell research, including the use of embryonic stem cells for medical research, raises significant ethical and policy concerns and, although not unique, the ethical and policy concerns associated with stem cell research must be carefully considered. Public policy on stem cell research shall balance ethical, societal, and medical considerations. The policy shall be based on an understanding of the science associated with stem cell research and grounded on a thorough consideration of the ethical concerns regarding this research.
Public policy on stem cell research shall be carefully crafted to ensure that researchers have the tools necessary to fulfill the promise of stem cell research. New York State shall regulate this important emerging technology in order to protect society from known risks. Human reproductive cloning poses risks that far outweigh its benefits.
New York State needs to develop a mechanism to transfer unused genetic material to research institutions. Donors must be well informed of their choices prior to making decisions for the disposition of their genetic material. potential donors of genetic material for stem cell research will be thoroughly protected by a rigorous, comprehensive informed consent procedure.
Legislative history
2004 - S.7064 2005/06 - S.433B
Fiscal implications
None.
Effective date
120 Days after it shall have become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.